EdgarLookup

Northwest Natural Holding Co — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Northwest Natural Holding Co filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
8.8%
Profit Margin
Net income ÷ revenue
1.8%
Return on Assets
Net income ÷ assets
+11.8%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.29B Feb 27, 2026
FY2025 Dec 31, 2024 $1.15B Feb 27, 2026
FY2025 Dec 31, 2023 $1.20B Feb 27, 2026
FY2024 Dec 31, 2022 $1.04B Feb 28, 2025
FY2023 Dec 31, 2021 $860.40M Feb 23, 2024
FY2022 Dec 31, 2020 $773.68M Feb 24, 2023
FY2019 Dec 31, 2019 $247.27M Mar 2, 2020
FY2019 Sep 30, 2019 $90.32M Mar 2, 2020
FY2019 Jun 30, 2019 $123.43M Mar 2, 2020
FY2019 Mar 31, 2019 $285.35M Mar 2, 2020

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $113.32M Feb 27, 2026
FY2025 Dec 31, 2024 $78.87M Feb 27, 2026
FY2025 Dec 31, 2023 $93.87M Feb 27, 2026
FY2024 Dec 31, 2022 $86.30M Feb 28, 2025
FY2023 Dec 31, 2021 $78.67M Feb 23, 2024
FY2022 Dec 31, 2020 $76.78M Feb 24, 2023
FY2019 Dec 31, 2019 $36.74M Mar 2, 2020
FY2019 Sep 30, 2019 ($19.30M) Mar 2, 2020
FY2019 Jun 30, 2019 $1.10M Mar 2, 2020
FY2019 Mar 31, 2019 $43.20M Mar 2, 2020

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $280.89M Feb 27, 2026
FY2025 Dec 31, 2024 $191.14M Feb 27, 2026
FY2025 Dec 31, 2023 $184.94M Feb 27, 2026
FY2024 Dec 31, 2022 $167.48M Feb 28, 2025
FY2023 Dec 31, 2021 $163.12M Feb 23, 2024
FY2022 Dec 31, 2020 $148.35M Feb 24, 2023
FY2021 Dec 31, 2019 $143.47M Feb 25, 2022
FY2020 Dec 31, 2018 $132.16M Feb 26, 2021
FY2019 Dec 31, 2017 $150.90M Mar 2, 2020
FY2018 Dec 31, 2016 $150.72M Mar 1, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $269.12M Feb 27, 2026
FY2025 Dec 31, 2024 $200.28M Feb 27, 2026
FY2025 Dec 31, 2023 $279.95M Feb 27, 2026
FY2024 Dec 31, 2022 $147.67M Feb 28, 2025
FY2023 Dec 31, 2021 $160.35M Feb 23, 2024
FY2022 Dec 31, 2020 $145.32M Feb 24, 2023
FY2021 Dec 31, 2019 $186.01M Feb 25, 2022
FY2020 Dec 31, 2018 $168.77M Feb 26, 2021
FY2019 Dec 31, 2017 $206.70M Mar 2, 2020
FY2018 Dec 31, 2016 $222.15M Mar 1, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $466.89M Feb 27, 2026
FY2025 Dec 31, 2024 $394.40M Feb 27, 2026
FY2025 Dec 31, 2023 $327.35M Feb 27, 2026
FY2024 Dec 31, 2022 $338.60M Feb 28, 2025
FY2023 Dec 31, 2021 $293.89M Feb 23, 2024
FY2022 Dec 31, 2020 $273.02M Feb 24, 2023
FY2021 Dec 31, 2019 $223.47M Feb 25, 2022
FY2020 Dec 31, 2018 $214.64M Feb 26, 2021
FY2019 Dec 31, 2017 $213.33M Mar 2, 2020
FY2018 Dec 31, 2016 $138.36M Mar 1, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.17B Feb 27, 2026
FY2025 Dec 31, 2024 $5.23B Feb 27, 2026
FY2024 Dec 31, 2023 $4.87B Feb 28, 2025
FY2023 Dec 31, 2022 $4.75B Feb 23, 2024
FY2022 Dec 31, 2021 $4.06B Feb 24, 2023
FY2021 Dec 31, 2020 $3.76B Feb 25, 2022
FY2020 Dec 31, 2019 $3.43B Feb 26, 2021
FY2019 Dec 31, 2018 $3.24B Mar 2, 2020
FY2018 Dec 31, 2017 $3.04B Mar 1, 2019

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.48B Feb 27, 2026
FY2025 Dec 31, 2024 $1.39B Feb 27, 2026
FY2024 Dec 31, 2023 $1.28B Feb 28, 2025
FY2023 Dec 31, 2022 $1.18B Feb 23, 2024
FY2022 Dec 31, 2021 $935.15M Feb 24, 2023
FY2021 Dec 31, 2020 $888.73M Feb 25, 2022
FY2020 Dec 31, 2019 $866.00M Feb 26, 2021
FY2019 Dec 31, 2018 $762.63M Mar 2, 2020
FY2018 Dec 31, 2017 $742.78M Mar 1, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $370.82M Feb 27, 2026
FY2025 Dec 31, 2024 $183.80M Feb 27, 2026
FY2024 Dec 31, 2023 $163.34M Feb 28, 2025
FY2023 Dec 31, 2022 $149.28M Feb 23, 2024
FY2022 Dec 31, 2021 $70.57M Feb 24, 2023
FY2021 Dec 31, 2020 $69.23M Feb 25, 2022
FY2020 Dec 31, 2019 $49.93M Feb 26, 2021
FY2019 Dec 31, 2018 $8.95M Mar 2, 2020
FY2018 Dec 31, 2017 $0 Mar 1, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $435.82M Feb 27, 2026
FY2025 Dec 31, 2024 $402.93M Feb 27, 2026
FY2024 Dec 31, 2023 $399.91M Feb 28, 2025
FY2023 Dec 31, 2022 $376.47M Feb 23, 2024
FY2022 Dec 31, 2021 $355.78M Feb 24, 2023
FY2021 Dec 31, 2020 $336.52M Feb 25, 2022
FY2020 Dec 31, 2019 $318.45M Feb 26, 2021
FY2019 Dec 31, 2018 $312.18M Mar 2, 2020
FY2018 Dec 31, 2017 $302.35M Mar 1, 2019

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $36.67M Feb 27, 2026
FY2025 Dec 31, 2024 $38.49M Feb 27, 2026
FY2024 Dec 31, 2023 $32.92M Feb 28, 2025
FY2023 Dec 31, 2022 $29.27M Feb 23, 2024
FY2022 Dec 31, 2021 $18.56M Feb 24, 2023
FY2021 Dec 31, 2020 $30.17M Feb 25, 2022
FY2020 Dec 31, 2019 $9.65M Feb 26, 2021
FY2020 Dec 31, 2018 $12.63M Feb 26, 2021
FY2020 Dec 31, 2017 $3.47M Feb 26, 2021
FY2019 Dec 31, 2016 $3.52M Mar 2, 2020

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.43B Feb 27, 2026
FY2025 Dec 31, 2024 $1.71B Feb 27, 2026
FY2024 Dec 31, 2023 $1.58B Feb 28, 2025
FY2023 Dec 31, 2022 $1.34B Feb 23, 2024
FY2022 Dec 31, 2021 $1.04B Feb 24, 2023
FY2021 Dec 31, 2020 $955.43M Feb 25, 2022
FY2020 Dec 31, 2019 $881.06M Feb 26, 2021
FY2019 Dec 31, 2018 $736.24M Mar 2, 2020

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Feb 27, 2026
FY2025 Dec 31, 2024 2 Feb 27, 2026
FY2025 Dec 31, 2023 2 Feb 27, 2026
FY2024 Dec 31, 2022 2 Feb 28, 2025
FY2023 Dec 31, 2021 2 Feb 23, 2024
FY2022 Dec 31, 2020 2 Feb 24, 2023
FY2019 Dec 31, 2019 1 Mar 2, 2020
FY2019 Sep 30, 2019 0 Mar 2, 2020
FY2019 Jun 30, 2019 0 Mar 2, 2020
FY2019 Mar 31, 2019 1 Mar 2, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Feb 27, 2026
FY2025 Dec 31, 2024 2 Feb 27, 2026
FY2025 Dec 31, 2023 2 Feb 27, 2026
FY2024 Dec 31, 2022 2 Feb 28, 2025
FY2023 Dec 31, 2021 2 Feb 23, 2024
FY2022 Dec 31, 2020 2 Feb 24, 2023
FY2019 Dec 31, 2019 1 Mar 2, 2020
FY2019 Sep 30, 2019 0 Mar 2, 2020
FY2019 Jun 30, 2019 0 Mar 2, 2020
FY2019 Mar 31, 2019 1 Mar 2, 2020

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 41.56M Feb 27, 2026
FY2025 Dec 31, 2024 40.22M Feb 27, 2026
FY2024 Dec 31, 2023 37.63M Feb 28, 2025
FY2023 Dec 31, 2022 35.52M Feb 23, 2024
FY2022 Dec 31, 2021 31.13M Feb 24, 2023
FY2021 Dec 31, 2020 30.59M Feb 25, 2022
FY2020 Dec 31, 2019 30.47M Feb 26, 2021
FY2019 Dec 31, 2018 28.88M Mar 2, 2020
FY2018 Dec 31, 2017 28.74M Mar 1, 2019

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $77.31M Feb 27, 2026
FY2025 Dec 31, 2024 $72.85M Feb 27, 2026
FY2025 Dec 31, 2023 $67.34M Feb 27, 2026
FY2024 Dec 31, 2022 $62.77M Feb 28, 2025
FY2023 Dec 31, 2021 $55.92M Feb 23, 2024
FY2022 Dec 31, 2020 $55.42M Feb 24, 2023
FY2021 Dec 31, 2019 $53.34M Feb 25, 2022
FY2020 Dec 31, 2018 $51.31M Feb 26, 2021
FY2019 Dec 31, 2017 $53.96M Mar 2, 2020
FY2018 Dec 31, 2016 $51.51M Mar 1, 2019